The device company, however, experienced a slight decline in revenue from the fourth quarter of 2010, which sat at approximately $129.3 million. According to the news release, the sequential decrease was driven in part by approximately $4 million in seasonal capital purchases and back royalties related to a settlement in 4Q 2010.
Read the company news release about NuVasive’s financial results.
Related Articles on Device Company Financial Results:
InVivo Therapeutics Reports $1.28M Net Loss in Q1
Bacterin Reports $6M in Q1 Revenue, 119% Increase
SANUWAVE Posts Q1 $252K Revenue, 76% Increase
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
